These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1372867)

  • 1. Diminished capacity to release metabolites of nitric oxide synthase in macrophages loaded with oxidized low-density lipoproteins.
    Jorens PG; Rosseneu M; Devreese AM; Bult H; Marescau B; Herman AG
    Eur J Pharmacol; 1992 Feb; 212(1):113-5. PubMed ID: 1372867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of oxidized low-density lipoprotein on immune-stimulated nitric oxide and prostaglandin release in macrophages.
    Matthys KE; Van Hove CE; Jorens PG; Rosseneu M; Marescau B; Herman AG; Bult H
    Eur J Pharmacol; 1996 Feb; 298(1):97-103. PubMed ID: 8867925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins.
    Yang X; Cai B; Sciacca RR; Cannon PJ
    Circ Res; 1994 Feb; 74(2):318-28. PubMed ID: 7507415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide.
    Bolton EJ; Jessup W; Stanley KK; Dean RT
    Atherosclerosis; 1994 Apr; 106(2):213-23. PubMed ID: 8060381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages.
    Liu SX; Chen Y; Zhou M; Wan J
    Atherosclerosis; 1998 Jan; 136(1):43-9. PubMed ID: 9544730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages.
    Eason S; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):225-40. PubMed ID: 8861714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis.
    Yang X; Galeano NF; Szabolcs M; Sciacca RR; Cannon PJ
    J Nutr; 1996 Apr; 126(4 Suppl):1072S-5S. PubMed ID: 8642435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation.
    Goureau O; Lepoivre M; Becquet F; Courtois Y
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4276-80. PubMed ID: 7683432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells.
    Baydoun AR; Bogle RG; Pearson JD; Mann GE
    Br J Pharmacol; 1993 Dec; 110(4):1401-6. PubMed ID: 7508326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide.
    Salvemini D; Pistelli A; Mollace V; Anggård E; Vane J
    Biochem Pharmacol; 1992 Jul; 44(1):17-24. PubMed ID: 1378739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypochlorite-oxidized low density lipoproteins reduce production and bioavailability of nitric oxide in RAW 264.7 macrophages by distinct mechanisms.
    Schmid W; Lee A; Son J; Koller E; Volf I
    Life Sci; 2008 Jul; 83(1-2):50-8. PubMed ID: 18558412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat, mouse and human neutrophils stimulated by a variety of activating agents produce much less nitrite than rodent macrophages.
    Padgett EL; Pruett SB
    Immunology; 1995 Jan; 84(1):135-41. PubMed ID: 7534260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis and induction of nitric oxide synthase in murine macrophages.
    Cunha FQ; Assreuy J; Moncada S; Liew FY
    Immunology; 1993 Jul; 79(3):408-11. PubMed ID: 7691724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I and transforming growth factor beta gene expression in rat macrophages.
    Dulak J; Polus M; Guevara I; Hartwich J; Wybrańska I; Krzesz R; Dembińska-Kieć A
    J Physiol Pharmacol; 1999 Sep; 50(3):429-41. PubMed ID: 10574472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
    Geng YJ; Hansson GK
    J Clin Invest; 1992 Apr; 89(4):1322-30. PubMed ID: 1556191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-arginine-dependent formation of N-nitrosamines by the cytosol of macrophages activated with lipopolysaccharide and interferon-gamma.
    Ohshima H; Tsuda M; Adachi H; Ogura T; Sugimura T; Esumi H
    Carcinogenesis; 1991 Jul; 12(7):1217-20. PubMed ID: 1712676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in nitric oxide synthase activity in a macrophage-like cell line, RAW264.7 cells, treated with lipopolysaccharide (LPS) in the presence or absence of interferon-gamma (IFN-gamma): possible heterogeneity of iNOS activity.
    Noda T; Amano F
    J Biochem; 1997 Jan; 121(1):38-46. PubMed ID: 9058189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms.
    Dusting GJ; Akita K; Hickey H; Smith M; Gurevich V
    Br J Pharmacol; 1999 Sep; 128(2):337-44. PubMed ID: 10510443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.